Metraipolis › archive › dc_c949593d152c

Real-world persistence and compliance of denosumab versus alendronate among postmenopausal women with osteoporosis in Asia-Pacific — Europe PMC PMID:41258429

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41258429
DOI
10.1007/s00774-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-08T10:46:12.110Z
SHA-256 of the archived text
ff92cc905967077b9e9a6a89b1ff29a534a918ce0dd8ab2b7fff9999e71ed7a0
Stable URL of this page
https://metraipolis.com/documento/dc_c949593d152c

How to cite

Real-world persistence and compliance of denosumab versus alendronate among postmenopausal women with osteoporosis in Asia-Pacific — Europe PMC PMID:41258429 — Europe PMC (en), https://europepmc.org/article/MED/41258429 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c949593d152c (Metraipolis archive dc_c949593d152c, sha256 ff92cc905967077b9e9a6a89b1ff29a534a918ce0dd8ab2b7fff9999e71ed7a0)
BibTeX
@misc{dcc949593d152c,
  title = {Real-world persistence and compliance of denosumab versus alendronate among postmenopausal women with osteoporosis in Asia-Pacific — Europe PMC PMID:41258429},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41258429},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c949593d152c; sha256 ff92cc905967077b9e9a6a89b1ff29a534a918ce0dd8ab2b7fff9999e71ed7a0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41258429. Agents can read the archived copy with the MCP tool read_document.